How Bioprinting Works & How We Save You Time & Money
Despite the diversity in methods, the Excedr lease program is able to source all instrument types and can accommodate any brand preferences your end-user might have. Request an estimate today and see how leasing can discount your bioprinter’s price.
All equipment brands/models are available
The Advantages of Excedr’s Bioprinter Leasing Program:
- Eliminates the upfront cost of purchasing equipment by spreading its cost over time
- Minimizes equipment downtime with included complete repair coverage and preventive maintenance
- Takes advantage of potentially 100% tax deductible* payments, providing you significant cash-savings
- Expedites the administrative work needed for instrument procurement and logistics
- Conserves working capital, enabling you to reinvest in your core business and operations (staffing, inventory, marketing/sales, etc.)
- Accommodates all manufacturer and model preferences
*Please consult your tax advisor to determine the full tax implications of leasing equipment.
Bioprinting utilizes 3D printing technologies for a multitude of tasks and applications in the fields of medicine, bioengineering, and pharmaceuticals.
This technology, which consists of different fabrication techniques, such as extrusion-, laser-, and inkjet-based 3D bioprinting techniques, focuses specifically on cell and tissue growth, as well as the manufacturing of biomaterials for biomedical parts.
It’s considered a form of additive manufacturing (AM) and rapid prototyping. However, unlike 3D printers, 3D bioprinters is used to reconstruct biological material and create tissue-like structures from various regions of the body using cell-encapsulating hydrogel bioinks reinforced with extracellular matrix derived from decellularized tissue. Simply put, 3D bioprinting—in conjunction with bioreactor systems—can be used for engineering human tissue.
Different cell types and bioinks are used depending on what’s being fabricated. Each bioink can be made with a specific type of material composed of living cells and additional polymers, such as collagen, gelatin, hyaluronan, and nanocellulose, and knowing what properties each bioink has is critical to tissue engineering’s success. The main bioink properties that should be considered include viscosity, gelation, and crosslinking.
Crosslinking is a crucial step that significantly influences the mechanical and physicochemical characteristics of the bioprinted constructs and the cellular behavior of the incorporated cells in the bioink.
One of the most common materials used for hydrogel-based tissue engineering and drug delivery is alginate. It is a type of biocompatible hydrogel with a wide pore distribution and physical properties that can potentially be tailored to direct 3D cell growth and differentiation in vitro and in vivo. It shows strong crosslinking capabilities, and exhibits high viscosity and gelling properties.
In tissue engineering, the cell type used alongside a specific bioink depends on the tissue model. For example, if the model is the brain, then you might see neural stem cells being used alongside a polyurethane-based bioink.
Being able to print structures that mimic both micro- and macro-environments of human organs and tissue can be incredibly important in clinical trials and drug testing, as well as testing treatments for diseases.
Bioprinting has already aided in the creation of necessary biological materials and cells for medical procedures that involve repairing damaged tissues, as there is often a shortage of these things, and has the potential for so much more.
Key bioprinting applications include tissue engineering and regenerative medicine (TERM) and biomaterial and drug printing, printing living tissues, skin grafts, and organs, as well as tissue models for cancer research and drug and toxicology screening.
These applications are possible due in large part to the combination of nano-biomaterials and bioprinting, which has allowed for new opportunities in biofabrication, improving weaknesses in the biofabrication process and making the production of tissues and organs feasible.
Bioprinter Processes, Methods, & Price
The basic 3D bioprinting process is similar to the 3D printing process. However, bioprinting replaces 3D printer materials with cells and biomaterials. It consists of three distinct phases: pre-processing, processing, and post-processing.
High-Resolution 3D Bioprinter Leases to Fit Every Need
Although bioprinting technology has only recently seen significant advancements, it has already shown that it has the potential to help countless lives.
Although there still remains much to be learned, the technology is positioned to be a disruptive and beneficial method in many fields of medicine and pharmaceuticals.
While purchasing 3D bioprinters, and lab equipment in general, can pose burdensome financial hurdles, leasing is an excellent alternative that the life sciences has explored much less than many other industries.
We offer comprehensive lease programs that spreads the cost of your machinery out over time, and includes preventative maintenance and repair coverage.
Contact us today to learn more about leasing 3D bioprinters, 3D printers, or any other additive manufacturing technology.
This off-balance sheet financing structure provides three options at the end of the term. The lessee has the option to return the equipment to the lessor, renew at a discounted rate, or purchase the instrument for the fair market value. Monthly payments are also 100% tax deductible which yields additional monetary savings.
If you recently bought equipment, Excedr can offer you cash for your device and convert your purchase into a long-term rental. This is called a sale-leaseback. If you’ve paid for equipment within the last ninety days, we can help you recoup your investment and allow you to make low monthly payments. This also frees up money in your budget rather than tying it down to a fixed asset.